223 related articles for article (PubMed ID: 21143373)
1. In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.
Armstrong PC; Leadbeater PD; Chan MV; Kirkby NS; Jakubowski JA; Mitchell JA; Warner TD
J Thromb Haemost; 2011 Mar; 9(3):552-61. PubMed ID: 21143373
[TBL] [Abstract][Full Text] [Related]
2. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic interplay of the P2Y(1), P2Y(12), and TxA(2) pathways in platelets: the potential of triple antiplatelet therapy with P2Y(1) receptor antagonism.
Oestreich JH; Ferraris SP; Steinhubl SR; Akers WS
Thromb Res; 2013 Feb; 131(2):e64-70. PubMed ID: 23245937
[TBL] [Abstract][Full Text] [Related]
4. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
[TBL] [Abstract][Full Text] [Related]
5. Aspirin withdrawal in patients treated with ticagrelor presenting with non-ST elevation myocardial infarction.
Beigel R; Mazin I; Koifman E; Shechter M; Pres H; Shlomo N; Rosenberg N; Asher E; Matetzky S
J Thromb Haemost; 2018 Apr; 16(4):663-669. PubMed ID: 29443445
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
7. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
9. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of U46619 induced human platelet aggregation by aspirin.
Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
[TBL] [Abstract][Full Text] [Related]
11. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
[TBL] [Abstract][Full Text] [Related]
12. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
Storey RF; Newby LJ; Heptinstall S
Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
14. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
15. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.
Armstrong PC; Truss NJ; Ali FY; Dhanji AA; Vojnovic I; Zain ZN; Bishop-Bailey D; Paul-Clark MJ; Tucker AT; Mitchell JA; Warner TD
J Thromb Haemost; 2008 Nov; 6(11):1933-43. PubMed ID: 18752570
[TBL] [Abstract][Full Text] [Related]
17. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y
Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y
Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825
[TBL] [Abstract][Full Text] [Related]
18. Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individuals.
McGlasson DL; Shah AD; Fritsma GA
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):583-7. PubMed ID: 21799401
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation and inhibition in sickle cell disease (pains) study.
Frelinger AL; Jakubowski JA; Brooks JK; Carmichael SL; Berny-Lang MA; Barnard MR; Heeney MM; Michelson AD
Platelets; 2014; 25(1):27-35. PubMed ID: 23469943
[TBL] [Abstract][Full Text] [Related]
20. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing.
Chan MV; Armstrong PC; Papalia F; Kirkby NS; Warner TD
Platelets; 2011; 22(7):485-94. PubMed ID: 21806492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]